Skip to content

Clinical trials

Dermatitis, Atopic trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Country / region: Singapore Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20181
20194
20202
20222
20234
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
National University of Singapore3
ASLAN Pharmaceuticals2
Amgen2
Eli Lilly and Company2
Regeneron Pharmaceuticals2
Danone Asia Pacific Holdings Pte, Ltd.1
Galderma R&D1
Hyphens Pharma Pte Ltd1
NAOS Argentina S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic21
Eczema8
Dermatitis3
Hypersensitivity3
Skin Diseases2
Communicable Diseases1
Growth Disorders1
Neurobehavioral Manifestations1
Pediatric Obesity1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.